Source: motorolka / Shutterstock.com It’s been a volatile start to the second quarter for many sectors. However, investors continue to seek out undervalued biotech stocks for robust returns over the long term. Plenty of options exist in various niches within the biotech sector. That said, investor focus remains on key sectors, including weight-loss drugs, Parkinson’s …
Continue reading “3 High-Growth Biotech Stocks Investors Shouldn’t Sleep On in April”